Barinthus Biotherapeutics plc. — Director's Dealing 2021

May 6, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Vaccitech plc (VACC)
CIK: 0001828185
Period of Report: 2021-05-04

Reporting Person: Ellis Christopher (Chief Operating Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-05-04	Ordinary Shares	P	75	$17	Acquired	75	Direct

Footnotes

F1: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.